Pyrimidine ribonucleoside monophosphate metabolic process

pathway activity — cross-omics
GO:0009173Cross-omicsPROTEIN-MS → RNACellPairwise association · TCGA cohorts

Across TCGA cell cohorts, RNA activity of the Pyrimidine ribonucleoside monophosphate metabolic process pathway is significantly associated with the RNA expression of multiple genes, with the BLOOD_Lymphoma cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are B4GALT1, CTSD, and ITGA5, each associated with the pathway in up to 6 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Pyrimidine ribonucleoside monophosphate metabolic process activity versus B4GALT1 in BLOOD_Lymphoma (Pearson r = -0.52).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BLOOD_LymphomaB4GALT1 →-1.355-0.206.009.00835
BLOOD_LymphomaCTSD →-1.277-0.193<.001.00226
CNSITGA5 →-1.620-0.503.004.00735
LUNG_SCLCTBC1D2 →-1.367-0.268<.001.00234
BLOOD_LymphomaCD99L2 →-1.373-0.206<.001.00334
LUNG_SCLCSLC35B2 →-0.882-0.246.003.00534
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0009173 vs B4GALT1 — BLOOD_Lymphoma

Per-sample scatter of Pyrimidine ribonucleoside monophosphate metabolic process activity vs B4GALT1 in BLOOD_Lymphoma.

Explore this scatter interactively →

Exploration